Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Boehringer Ingelheim Pharmaceuticals, Inc. to request your refund or repair — edit it as you like.
Subject: Recall D-0991-2019 — Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mirap Hello, I own a Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, that is covered by recall D-0991-2019 from Boehringer Ingelheim Pharmaceuticals, Inc.. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
